A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

383

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Type 2 Diabetes
Interventions
DRUG

LY3502970

Administered orally

DRUG

Dulaglutide

Administered subcutaneously

DRUG

Placebo

Administered orally

DRUG

Placebo

Administered subcutaneously

Trial Locations (44)

1032

Szent Margit Rendelőintézet Nonprofit Kft, Budapest

1033

Clinexpert Kft., Budapest

1089

ClinDiab Kft., Budapest

1213

TRANTOR'99 Bt. Anyagcsere Centrum, Budapest

3200

Bugát Pál Kórház, Gyöngyös

8800

Kanizsai Dorottya Korhaz, Nagykanizsa

8900

Zala Megyei Szent Rafael Kórház, Zalaegerszeg

17011

Capital Area Research, LLC, Camp Hill

19056

Family Medical Associates, Levittown

19114

Tristar Clinical Investigations, Philadelphia

65807

Clinvest Research LLC, Springfield

66606

Cotton O'Neil Clinical Research Center, Topeka

73069

Intend Research, LLC, Norman

75230

Dallas Diabetes Research Center, Dallas

77084

Biopharma Informatic, LLC, Houston

78231

Consano Clinical Research, LLC, Shavano Park

78249

Bandera Family Health Care, San Antonio

80132

Optumcare Colorado Springs - Monument, Monument

80401

New West Physicians Clinical Research, Golden

90057

Velocity Clinical Research, Westlake, Los Angeles

90255

Velocity Clinical Research, Huntington Park, Huntington Park

91730

Rancho Cucamonga Clinical Research, Rancho Cucamonga

92801

Anaheim Clinical Trials, LLC, Anaheim

94592

Touro University California, Vallejo

98052

Eastside Research Associates, Redmond

98502

Capital Clinical Research Center, Olympia

08611

Premier Research, Trenton

H1171

Strazsahegy Medicina Bt., Budapest

33-122

Centrum Zdrowia Tuchów, Wierzchosławice

50-403

Wojewódzki Zespól Specjalistycznej Opieki Zdrowotnej, Wroclaw

20-333

Gabinety TERPA, Lublin

20-538

NZOZ Medica, Lublin

02-507

Centralny Szpital Kliniczny MSWiA w Warszawie, Warsaw

80-546

Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk

41-709

NZOZ Przychodnia Specjalistyczna Andrzej Wittek, Henryk Rudzki, Ruda Śląska

Unknown

Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna, Lodz

00646

Dorado Medical Complex, Dorado

00780

Clinical Research Management Group Inc. - Hospital San Cristobal, Ponce

00907

BRCR Global Puerto Rico-Unda, San Juan

831 06

Ambulancia diabetológie a porúch látkovej premeny a výživy - DIABEDA, Bratislava

080 01

Diabetol, Prešov

083 01

MEDI-DIA s.r.o., Sabinov

020 01

DIA-MED CENTRUM s.r.o., Púchov

940 01

Funkystuff, Nové Zámky

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT05048719 - A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter